Podcast- Arshed A. Quyyumi , MD- Effects of a Health‐Partner Intervention on Cardiovascular Risk #Emory #EmoryUnive...

2 years 96 Views

Dr. Quyyumi is a tenured Professor of Medicine in Emory University School of Medicine's Division of Cardiology and Director of the Emory Clinical Cardiovascular Research Institute. In this video Dr. Quyyumi discusses the Effects of a Health‐Partner Intervention on Cardiovascular Risk.

Link to Abstract-

Lifestyle changes are the first line of defense against cardiovascular disease. It's less apparent whether a healthy lifestyle can also help with cardiovascular health. Our research looked at the impact of a lifestyle intervention provided by a Health Partner on indicators of optimum cardiovascular health.

Results and Methods
At Emory University, 711 university employees (4811 years old; 66 percent women, 72 percent Caucasian/22.5 percent African Americans) participated in a program promoting healthy living (Atlanta, GA). At baseline, 6 months, 1 year, and 2 years after that, anthropometric, laboratory, and physical activity measurements were taken. The Health Partner used the results to create a customised plan aimed at achieving ideal health metrics. At the 6-month, 1-year, and 2-year follow-up visits, systolic blood pressure was lower by 3.6, 4.6, and 3.3 mm Hg (P0.001), total cholesterol was lower by 5.3, 6.5, and 6.4 mg/dL (P0.001), body mass index was lower by 0.33, 0.45, and 0.38 kg/m2 (P0.001), and the percentage of smokers was lower by 1.3 percent, 3.5 percent, and 3.5 percent The changes were more pronounced in those who had more anomalies at the start. Finally, compared to the baseline visit, the American Heart Association "Life's Simple 7" ideal cardiovascular health score increased by 0.28, 0.40, and 0.33 at 6 months, 1 year, and 2 years.

A personalized, goal-directed Health Partner intervention reduced the cardiometabolic risk profile and cardiovascular health measures dramatically. These effects were visible six months after enrollment and lasted for two years. More research is needed to see if the Health Partner intervention reduces long-term morbidity and mortality while remaining cost-effective. /